Rettig B, Nelson N, Faulk R
Nebraska Department of Health, Lincoln 68509.
Nebr Med J. 1994 May;79(5):136-8; discussion 139.
Although the efficacy of screening mammography has been surrounded in controversy of late, the evidence that it can reduce breast cancer mortality among women 50-74 years of age is extremely sound. In Nebraska, data from the state's Behavioral Risk Factor Survey show, that during the years 1988 to 1992, the percentage of women age 50 years and older who had ever had a mammogram rose from 50% to 65%, while the percentage of women of the same age who had had a mammogram within the past year rose from 24% to 34%. Nebraska BRFS data also show that the percentage of women 50 years of age and older who have had a mammogram within the past year varies considerably by age, income, education, and county of residence. Among women who have not had a mammogram within the past year, 66% reported that they had seen a physician within the past year for a routine check-up. Prompt and appropriate follow-up of abnormal findings by both physicians and health-care organizations is also essential to ensure the maximum benefit of screening mammography.
尽管近年来乳腺钼靶筛查的有效性一直存在争议，但有确凿证据表明，它能降低50至74岁女性的乳腺癌死亡率。在 Nebraska，该州行为危险因素调查的数据显示，在1988年至1992年期间，50岁及以上曾接受过乳腺钼靶检查的女性比例从50%升至65%，而在过去一年接受过乳腺钼靶检查的同年龄段女性比例则从24%升至34%。Nebraska BRFS数据还表明，过去一年接受过乳腺钼靶检查的50岁及以上女性比例，因年龄、收入、教育程度和居住县的不同而有很大差异。在过去一年未接受乳腺钼靶检查的女性中，66%报告称她们在过去一年曾因常规体检看过医生。医生和医疗保健机构对异常检查结果进行及时、恰当的跟进，对于确保乳腺钼靶筛查的最大益处也至关重要。
